UPDATE : Wednesday, June 19, 2019
상단여백
Daewoong’s pulmonary fibrosis treatment wins government support by Lee Han-soo 2019-03-08 16:57
Gilead, Yuhan to co-promote Biktarvy by Lee Han-soo 2019-03-08 15:32
Roche Korea’s combo therapy gets nod as 1st-line lung cancer therapy by Lee Han-soo 2019-03-08 14:38
Sanofi Genzyme’s Gaucher disease treatment gets more insurance benefit by Lee Han-soo 2019-03-07 16:22
Daewoong marks record-high sales in 2018 by Lee Han-soo 2019-03-07 16:01
라인
When will NOAC reversal agents be available in Korea? by Kim Yun-mi 2019-03-07 15:52
Off-label use of sirolimus for pediatric pulmonary vein stenosis banned by Lee Hye-seon 2019-03-07 15:10
Amgen’s Xgeva solves adverse effect problems by Lee Han-soo 2019-03-07 14:25
‘Korean drugmakers can tap US generic market’ by Jeong Sae-im 2019-03-07 11:54
Chinese partner to start trials for Genexine’s immunotherapeutic drug candidate by Lee Han-soo 2019-03-06 14:27
라인
Binex, Chongqing Zein to establish joint company by Lee Han-soo 2019-03-06 13:41
Medytox keeps urging Daewoong to clarify suspicions over BTX’s origin by Lee Han-soo 2019-03-05 16:22
Hanmi’s acute myeloid leukemia wins developmental stage orphan drug status by Lee Han-soo 2019-03-05 15:34
Handok to market Amicus Therapeutics’ Fabry disease treatment by Lee Han-soo 2019-03-05 15:11
Lilly Korea to test rheumatoid arthritis drug for hair loss treatment by Lee Hye-seon 2019-03-05 15:10
라인
3rd-generation antiepileptic drug lands on Korea by Lee Hye-seon 2019-03-05 14:42
IVI gets $3.2 million for typhoid conjugate vaccine study in W. Africa by Lee Han-soo 2019-03-05 14:41
Hanmi releases P4 clinical trials for anti-hypertension treatment by Lee Han-soo 2019-03-04 17:01
Regulator expands XGEVA’s indication for use by multiple myeloma patients by Kim Yun-mi 2019-03-04 16:02
AbbVie gets positive views for treatment of plaque psoriasis in EU by Lee Han-soo 2019-03-04 15:57
여백
여백
여백
Back to Top